Research article Special Issues

Identifying key transcription factors and miRNAs coregulatory networks associated with immune infiltrations and drug interactions in idiopathic pulmonary arterial hypertension


  • Background 

    The deregulated genetic factors are critically associated with idiopathic pulmonary arterial hypertension (IPAH) development and progression. However, the identification of hub-transcription factors (TFs) and miRNA-hub-TFs co-regulatory network-mediated pathogenesis in IPAH remains lacking.

    Methods 

    We used GSE48149, GSE113439, GSE117261, GSE33463, and GSE67597 for identifying key genes and miRNAs in IPAH. We used a series of bioinformatics approaches, including R packages, protein-protein interaction (PPI) network, and gene set enrichment analysis (GSEA) to identify the hub-TFs and miRNA-hub-TFs co-regulatory networks in IPAH. Also, we employed a molecular docking approach to evaluate the potential protein-drug interactions.

    Results 

    We found that 14 TFs encoding genes, including ZNF83, STAT1, NFE2L3, and SMARCA2 are upregulated, and 47 TFs encoding genes, including NCOR2, FOXA2, NFE2, and IRF5 are downregulated in IPAH relative to the control. Then, we identified the differentially expressed 22 hub-TFs encoding genes, including four upregulated (STAT1, OPTN, STAT4, and SMARCA2) and 18 downregulated (such as NCOR2, IRF5, IRF2, MAFB, MAFG, and MAF) TFs encoding genes in IPAH. The deregulated hub-TFs regulate the immune system, cellular transcriptional signaling, and cell cycle regulatory pathways. Moreover, the identified differentially expressed miRNAs (DEmiRs) are involved in the co-regulatory network with hub-TFs. The six hub-TFs encoding genes, including STAT1, MAF, CEBPB, MAFB, NCOR2, and MAFG are consistently differentially expressed in the peripheral blood mononuclear cells of IPAH patients, and these hub-TFs showed significant diagnostic efficacy in distinguishing IPAH cases from the healthy individuals. Moreover, we revealed that the co-regulatory hub-TFs encoding genes are correlated with the infiltrations of various immune signatures, including CD4 regulatory T cells, immature B cells, macrophages, MDSCs, monocytes, Tfh cells, and Th1 cells. Finally, we discovered that the protein product of STAT1 and NCOR2 interacts with several drugs with appropriate binding affinity.

    Conclusions 

    The identification of hub-TFs and miRNA-hub-TFs co-regulatory networks may provide a new avenue into the mechanism of IPAH development and pathogenesis.

    Citation: Qian Li, Minawaer Hujiaaihemaiti, Jie Wang, Md. Nazim Uddin, Ming-Yuan Li, Alidan Aierken, Yun Wu. Identifying key transcription factors and miRNAs coregulatory networks associated with immune infiltrations and drug interactions in idiopathic pulmonary arterial hypertension[J]. Mathematical Biosciences and Engineering, 2023, 20(2): 4153-4177. doi: 10.3934/mbe.2023194

    Related Papers:

    [1] Zhe Su, Yiying Tong, Guo-Wei Wei . Persistent de Rham-Hodge Laplacians in Eulerian representation for manifold topological learning. AIMS Mathematics, 2024, 9(10): 27438-27470. doi: 10.3934/math.20241333
    [2] Ruzhi Song, Fengling Li, Jie Wu, Fengchun Lei, Guo-Wei Wei . Multi-scale Jones polynomial and persistent Jones polynomial for knot data analysis. AIMS Mathematics, 2025, 10(1): 1463-1487. doi: 10.3934/math.2025068
    [3] Huan Xu, Tao Yu, Fawaz E. Alsaadi, Madini Obad Alassafi, Guidong Yu, Jinde Cao . Some spectral sufficient conditions for a graph being pancyclic. AIMS Mathematics, 2020, 5(6): 5389-5401. doi: 10.3934/math.2020346
    [4] Li Shen, Jian Liu, Guo-Wei Wei . Evolutionary Khovanov homology. AIMS Mathematics, 2024, 9(9): 26139-26165. doi: 10.3934/math.20241277
    [5] Wei Xue, Pengcheng Wan, Qiao Li, Ping Zhong, Gaohang Yu, Tao Tao . An online conjugate gradient algorithm for large-scale data analysis in machine learning. AIMS Mathematics, 2021, 6(2): 1515-1537. doi: 10.3934/math.2021092
    [6] Shama Liaqat, Zeeshan Saleem Mufti, Yilun Shang . Newly defined fuzzy Misbalance Prodeg Index with application in multi-criteria decision-making. AIMS Mathematics, 2024, 9(8): 20193-20220. doi: 10.3934/math.2024984
    [7] Jinfang Li, Chunjiang Wang, Li Zhang, Jian Zhang . Multi-solitons in the model of an inhomogeneous optical fiber. AIMS Mathematics, 2024, 9(12): 35645-35654. doi: 10.3934/math.20241691
    [8] Qingbing Liu, Aimin Xu, Shuhua Yin, Zhe Tu . A note on the preconditioned tensor splitting iterative method for solving strong M-tensor systems. AIMS Mathematics, 2022, 7(4): 7177-7186. doi: 10.3934/math.2022400
    [9] Muhammad Riaz, Khadija Akmal, Yahya Almalki, S. A. Alblowi . Cubic m-polar fuzzy topology with multi-criteria group decision-making. AIMS Mathematics, 2022, 7(7): 13019-13052. doi: 10.3934/math.2022721
    [10] Changlong Yu, Jing Li, Jufang Wang . Existence and uniqueness criteria for nonlinear quantum difference equations with p-Laplacian. AIMS Mathematics, 2022, 7(6): 10439-10453. doi: 10.3934/math.2022582
  • Background 

    The deregulated genetic factors are critically associated with idiopathic pulmonary arterial hypertension (IPAH) development and progression. However, the identification of hub-transcription factors (TFs) and miRNA-hub-TFs co-regulatory network-mediated pathogenesis in IPAH remains lacking.

    Methods 

    We used GSE48149, GSE113439, GSE117261, GSE33463, and GSE67597 for identifying key genes and miRNAs in IPAH. We used a series of bioinformatics approaches, including R packages, protein-protein interaction (PPI) network, and gene set enrichment analysis (GSEA) to identify the hub-TFs and miRNA-hub-TFs co-regulatory networks in IPAH. Also, we employed a molecular docking approach to evaluate the potential protein-drug interactions.

    Results 

    We found that 14 TFs encoding genes, including ZNF83, STAT1, NFE2L3, and SMARCA2 are upregulated, and 47 TFs encoding genes, including NCOR2, FOXA2, NFE2, and IRF5 are downregulated in IPAH relative to the control. Then, we identified the differentially expressed 22 hub-TFs encoding genes, including four upregulated (STAT1, OPTN, STAT4, and SMARCA2) and 18 downregulated (such as NCOR2, IRF5, IRF2, MAFB, MAFG, and MAF) TFs encoding genes in IPAH. The deregulated hub-TFs regulate the immune system, cellular transcriptional signaling, and cell cycle regulatory pathways. Moreover, the identified differentially expressed miRNAs (DEmiRs) are involved in the co-regulatory network with hub-TFs. The six hub-TFs encoding genes, including STAT1, MAF, CEBPB, MAFB, NCOR2, and MAFG are consistently differentially expressed in the peripheral blood mononuclear cells of IPAH patients, and these hub-TFs showed significant diagnostic efficacy in distinguishing IPAH cases from the healthy individuals. Moreover, we revealed that the co-regulatory hub-TFs encoding genes are correlated with the infiltrations of various immune signatures, including CD4 regulatory T cells, immature B cells, macrophages, MDSCs, monocytes, Tfh cells, and Th1 cells. Finally, we discovered that the protein product of STAT1 and NCOR2 interacts with several drugs with appropriate binding affinity.

    Conclusions 

    The identification of hub-TFs and miRNA-hub-TFs co-regulatory networks may provide a new avenue into the mechanism of IPAH development and pathogenesis.



    Human milk stored in human milk banks (HMBs) is the gold standard for feeding preterm neonates, especially those born before 32 weeks of age. To reduce the infectious risk linked to a possible contamination by harmful bacteria through human milk of these preterm neonates, pasteurization (mainly standard Holder pasteurization at 62.5 °C for 30 min) is carried out in HMBs to kill bacteria present in raw human milk. However, B. cereus endospores may not completely be eliminated by pasteurization and can therefore give rise to new vegetative forms of B. cereus in the milk post-pasteurization [1]. Additionally, several reports show that pasteurized human milk can be contaminated with Bacillus cereus [2][4]. This is a cause for concern as preterm neonates have previously been reported to be susceptible to severe cases of B. cereus infections [5],[6] and human breast milk was pointed out as a possible source of contamination [5],[7]. The most usual symptoms of B. cereus infections are diarrheal and emetic [8]. Diarrheal symptoms are caused by a variety of toxins such as pore-forming toxins hemolysin BL (Hbl) and non-hemolytic enterotoxin (Nhe) which both comprise three subunits, as well as cytotoxin K (cytK) [8],[9]. Additionally, enterotoxins entFM and bceT, encoded respectively by entFM and bceT, have also been proposed to play a part in diarrheic symptoms witnessed in B. cereus food poisoning [10],[11]. However, the enterotoxic properties of bceT were later questioned [12]. Meanwhile, the emetic form of B. cereus infection is driven by the action of cereulide toxin, a cyclic dodecadepsipeptide resistant to heat, proteolysis and acidic pH [9]. The latter toxin is encoded by genes found on a megaplasmid and its prevalence in B. cereus strains is relatively low, as compared to other toxins [9],[13]. A classification of B. cereus strains in seven different toxin profiles: A (nhe+, hbl+, cytK+), B (nhe+, cytK+, ces+), C (nhe+, hbl+), D (nhe+, cytK+), E (nhe+, ces+), F (nhe+) and G (cytK+) has been proposed [14].

    In Amiens-Picardie Human Milk Bank (APHMB), contamination rates with B. cereus of pasteurized milk have been shown to be the leading cause of milk rejection post-microbiological quality control [3]. Therefore, we endeavored to assess whether this contamination could (i) be due to B. cereus strains presenting a worrisome toxin expression profile and (ii) arise from the hospital environment, especially APHMB rooms, linen and materials, or simply from donating mothers. The toxin gene patterns from various B. cereus strains have been studied and seem to be influenced by their geographical and/or foodstuff origins [9]. It was hypothesized that toxin gene patterns could also help us in discerning B. cereus strains originating from human milk and the environment. Hence, the aims of this work were first to evaluate the pathogenic potential of strains isolated from human milk and then to compare toxin expression profiles in order to determine if the B. cereus contamination of pasteurized human milk in APHMB could arise from environmental strains or not. In a further attempt to differentiate between strains isolated from breast milk and those from the hospital environment, the results obtained were compared to those gathered through analysis of Fourier-transform infra-red (FTIR) spectra, a promising new method for the discrimination of bacterial isolates of the same species [15].

    A total of 63 B. cereus strains coming from human milk (HM) donations made to the Centre Hospitalier Universitaire APHMB were collected during a previously described study [3]. The study design was validated by the ad hoc Research Commission at the Centre Hospitalier Universitaire Amiens-Picardie (institutional review board) following the French Regulation [16]. In accordance with the European General Data Protection Regulation [17], the opinion of the Research Commission on the registration of the databank built for this study by the national commission in charge of data protection (Commission Nationale de l'Informatique et des Libertés) was also sought. The registration was deemed unnecessary (decision date: 24 April 2019).

    Twenty-seven environmental strains were retrieved from samples routinely collected through the hospital environment surveillance program. Those included samples coming from APHMB rooms (13 isolates) as well as other wards (4 isolates), linen (7 isolates) and endoscopes (3 isolates).

    All strains were identified using matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI Biotyper 2.2; Bruker Daltonik GmbH, Bremen, Germany). They were kept at –20 °C on cryobeads (Mast Diagnostic, Amiens, France) until use.

    Additionally, for the detection of toxin genes, several collection strains were included in the analysis as controls: B. cereus DSM 31, B. cereus DSM 4312 and B. cereus DSM 4313, (Deutsche Sammlung für Mikroorganismen und Zellkulturen, Braunschweig, Germany).

    DNA extraction was performed using DNeasy Tissue extraction kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions for Gram positive bacteria. Following the extraction procedure, DNA contents in extracts were measured using the Nanodrop apparatus (Thermo Fisher Scientific, Illkirch, France). Amplification of 16S rDNA (positive control), ces, bceT, cytK, nhe(ABC), and hbl(ACD) genes was performed with a Verity thermal cycler (Applied Biosystems, France) using primers previously described (Table 1). A 25 µL reaction volume consisting of 12.5 µL DreamTaq PCR Master Mix (Thermo Fisher Scientific), 1µL of forward and 1 µL of reverse primer (final concentration 0.2 to 0.5 µM), 4.5 µL molecular biology grade water and 5 µL of template DNA was submitted to amplification. The amplification typically consisted of 1 cycle at 94 °C for 5 min followed by 35 cycles including 1 min at 94 °C, 1 min at the mentioned annealing temperature and 2 min at 72 °C. A final elongation cycle at 72 °C for 5 min completed the amplification run. For ces amplification, the PCR protocol was composed of a denaturation step at 95 °C for 15 min followed by five cycles of 1 min at 95 °C, 75 s at 53 °C, and 50 s at 72 °C and then by 25 cycles of 1 min at 95 °C, 75 s at 58 °C, and 50s at 72 °C. A final elongation step consisting of 72 °C for 5 min ended the amplification procedure.

    Table 1.  Primer sequences and annealing conditions used in this study.
    Target gene Sequence (5′-3′) Annealing temperature (°C) Amplicon size (bp) Reference
    16S rDNA Fa: ACTCCTACGGGAGGCAG
    Ra: ATTACCGCGGCTGCTGGCA
    55 196 [18]
    bceT F: CGTATCGGTCGTTCACTCGG
    R: GTTGATTTTCCGTAGCCTGGG
    55 661 [19]
    ces F: GGTGACACATTATCATATAAGGTG
    R: GTAAGCGAACCTGTCTGTAACAACA
    53/58 1271 [20]
    cytK F: CGACGTCACAAGTTGTAACA
    R: CGTGTGTAAATACCCCAGTT
    54 565 [21]
    entFM F: GTTCGTTCAGGTGCTGGTAC
    R: AGCTGGGCCTGTACGTACTT
    54 486 [21]
    hblA F: AAGCAATGGAATACAATGGG
    R: AGAATCTAAATCATGCCACTGC
    56 1154 [19]
    hblC F: GATAC(T,C)AATGTGGCAACTGC
    R: TTGAGACTGCTCG(T,C)TAGTTG
    58 740 [19]
    hblD F: ACCGGTAACACTATTCATGC
    R: GAGTCCATATGCTTAGATGC
    58 829 [19]
    nheA F: TAAGGAGGGGCAAACAGAAG
    R: TGAATGCGAAGAGCTGCTTC
    54 759 [21]
    nheB F: CAAGCTCCAGTTCATGCGG
    R: GATCCCATTGTGTACCATTG
    54 935 [21]
    nheC F: ACATCCTTTTGCAGCAGAAC
    R: CCACCAGCAATGACCATATC
    54 618 [21]

    a: F=Forward primer/R=Reverse primer

    Amplification products were visualized by electrophoresis on a 1.5% agarose gel containing GelRed© nucleic acid stain (Merck Millipore, Molsheim, France) and run for 1h at 100V followed by UV transillumination on the IBright 1500© system (Thermo Fisher Scientific). Their size was estimated using Generuler DNA ladder (Thermo Fisher Scientific).

     | Show Table
    DownLoad: CSV

    All B. cereus strains were handled similarly to minimize differences in the carbohydrate, lipid and protein structures of the cell wall that might arise from variations in culture conditions. Frozen strains were subcultured twice on plate count agar (Biomérieux, Marcy l'étoile, France) for 18 to 24 hours at 36 ± 1 °C. Well individualized colonies were then processed using IR Biotyper R© kit (Bruker Daltonik GmbH) according to the manufacturer's instruction. Three replicates of each strain were submitted to FTIR analysis using the IR-Biotyper© system (Bruker Daltonik GmbH) in transmission mode in the spectral range of 4,000–500 cm–1 (mid-IR). For each run, quality control was performed with the InfraRed Test Standards (IRTS 1 and 2) in the IR Biotyper R© kit. Resulting spectra were analyzed using OPUS software V8.2.28 (Bruker Daltonik GmbH). Principal Component Analysis (PCA) was applied for multivariate analyses, using the IR Biotyper R© V3.1 software functionality.

    Comparison of the prevalences of toxin genes and toxin profiles between environmental and HM B. cereus strains was performed using Fisher exact test. A p-value below 0.05 was considered as significant.

    PCR efficiency was first checked for all DNA extracts with the amplification of a control gene (16S rDNA). All extracts gave positive results, validating the absence of inhibitory substances that might impair the amplification process. The prevalence of toxin genes and toxin profiles [16] are summarized in Table 2 and Figure 1, respectively. Even though no statistically significant differences in toxin gene prevalences were found between HM and environmental B. cereus isolates, prevalences of nheA, nheB, and ces in HM isolates failed to be qualified as higher than that of environment strains by a narrow margin (p = 0.054; p = 0.063 and p = 0.12, respectively; Fisher exact test). Similarly, no differences in toxin profiles could be highlighted by the statistical analysis comparing HM and environmental isolates.

    Table 2.  Prevalences of toxin genes in Bacillus cereus strains included in this study.
    Toxin genes Prevalences
    Overall (90)b Human Milk (63) Environment (27)
    bceT 38 (34) 38 (24) 37 (10)
    ces 27 (24) 32 (20) 15 (4)
    cytk 73 (66) 76 (48) 67 (18)
    entFM 92 (83) 92 (58) 93 (25)
    hblA 30 (27) 33 (21) 22 (6)
    hblC 29 (26) 32 (20) 22 (6)
    hblD 59 (53) 62 (39) 52 (14)
    nheA 86 (77) 90 (57) 74 (20)
    nheB 93 (84) 97 (61) 85 (23)
    nheC 90 (81) 92 (58) 85 (23)

    a: results expressed as percentage (number of positive isolates)

    b: number of isolates per category

     | Show Table
    DownLoad: CSV
    Figure 1.  Toxin profiles of Bacillus cereus strains included in this study. Toxin profiles are defined as follows: A = nhe+, hbl+, cytK+; B = nhe+, cytK+, ces+; C = nhe+, hbl+; D = nhe+, cytK+; E = nhe+, ces+; F = nhe+; G = cytK+ and Other = combination of genes different from those described for A to G profiles.

    A scatter-plot of PCA results from the 90 analyzed strains is displayed in Figure 2. A resulting calculated cut-off distance between isolates of 0.161 was set by the software to discriminate clusters of B. cereus isolates. A total of 33 clusters were thus obtained with 18 clusters containing a single isolate, 8 clusters containing either 2 or 3 isolates (4 clusters each). The largest clusters held 5 (1 cluster), 7 (3 clusters), 8 (2 clusters) and 11 (1 cluster) isolates, respectively.

    B. cereus is a facultative anaerobic, Gram-positive, spore-forming opportunistic pathogen. It is a common cause of food poisoning, the most usual symptoms of which are diarrheal and emetic [8]. One of its prominent virulence features is its ability to produce various toxins. Surprisingly, while plenty of literature can be found on the prevalence and distribution of toxin genes in B. cereus strains isolated from cow milk, dairy products and powdered milks, very few works report on these parameters in HM isolates. In the only study found available on the subject, forty-nine isolates (including 3 strains recovered post-pasteurization) were tested for the occurrence of toxin genes [22].

    Figure 2.  2D plot of the first two components arising from the primary component analysis comparing the 90 B. cereus strains included in this study (3 FITR spectra acquired per strain). Color coding for B. cereus isolates as follows: Raw Human Milk; Pasteurized Human Milk; Endoscope; Linen; Human Milk Bank Room 1; Human Milk Bank Room 2; Human Milk Bank Room 3; Other hospital wards. Shape coding of the 7 B. cereus main (5 isolates and more) clusters as follows: Lower ○ Cluster 1 (5 isolates); Upper ○ Cluster 2 (8 isolates); + Cluster 3 (7 isolates); Upper▼Cluster 4 (7 isolates); Lower ▼Cluster 5 (7 isolates); ▲Cluster 6 (8 isolates); ● Cluster 7 (11 isolates).

    Similar to the high prevalence witnessed in our work, all three nhe genes were nearly systematically detected in all but one isolates by these authors. High prevalences ranging from 78 to 100% were also reported for nhe in B. cereus strains isolated from other raw/pasteurized milk sources and fit with the values found in this work [23][27]. As for our hbl and cytK prevalences, they also fell within the ranges previously described in milk isolated (2 to 90% and 46 to 73%, respectively) [23],[25][27]. Regarding entFM and bceT presence in milk isolates, prevalences were less widely investigated in the literature. While our high entFM prevalence was in accordance with the ones already described [24],[25], the 24% prevalence witnessed for bceT was lower than those previously published [25],[27]. Finally, ces prevalence was null or very low in most previous works reporting on milk isolates [22][24],[26] when ces prevalence was higher (27%) in the isolates investigated here. Only two studies reported high prevalences for ces (10 and 16%, respectively) [25],[27] but none as high as the one found in this work, which is worrisome and supports the current French policy of discarding pasteurized milk displaying a bacterial contamination of 2 Colony Forming Units per milliliter or above [28]. This discrepancy in observed ces prevalences might be due to the fact that, as very few B. cereus were identified pre-pasteurization in this study, most of the isolates came from pasteurized milk. Indeed, Radmehr et al. already noted that isolates harvested post-pasteurization displayed more virulence genes than raw milk ones [26]. It could also be due to the spread of a B. cereus clone carrying ces in APHMB donations and environment.

    As for using toxin gene profiles to discriminate between our isolates, no statistically significant difference in toxin prevalences could be highlighted between environmental and HM isolates investigated in this work. However, ces could once more be qualified as concerning as its prevalence was close to being statistically higher in HM isolates than the prevalence in environmental ones. Nevertheless, according to the classification previously described by Ehling-Schulz et al., no discriminating pattern between environmental and HM isolates could be identified [14]. However, it must be underscored that this classification did not take into account strains carrying nhe, hbl, cytK and ces, nor did it include entFM. As a consequence, 13 of our isolates could not be assigned to a given toxin gene profile. We therefore sought another possibility to discriminate between our isolates, such as FTIR spectroscopy.

    FTIR spectroscopy has previously been described as being able to discriminate clones between strains of a given species in a time and cost-efficient manner both for Gram-negative and Gram-negative bacteria [15],[29][30]. It has also been reported as a helpful tool in discriminating B. cereus isolates [26]. The golden standard for discriminating bacterial isolates within a species is the whole genome sequencing (WGS) technique [15]. This method has allowed to drastically improve the discriminatory power over other molecular-based typing methods such as 16S rDNA sequencing, Pulse Field Gel Electrophoresis (PFGE) or Multilocus Sequence Typing (MLST) [15]. However, these molecular-based typing methods are universally recognized as time-consuming, costly and labor-intensive [31]. Several studies have described the interest of spectroscopic/spectrometric-based methods such as Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) and FTIR in typing bacterial isolates. A major advantage of these techniques is that, once the apparatus is present in a facility, they are easily integrated in the laboratory daily workflow. While MALDI-TOF MS is now routinely used for species identification in medical laboratories, its discrimination power when it comes to clonality assessment has been questioned [31],[32]. The choice of using FITR was therefore made for this work.

    Applied to our panel of isolates, FTIR showed that around 42% (38 isolates out of 90) were classified in clusters consisting of a single or 2 to 3 isolates. Hence, no common origin on which a corrective action might be implemented to mitigate the spread of B. cereus in pasteurized HM could be identified for those isolates. Nevertheless, more than half of our isolates were grouped in seven clusters of 5 or more isolates (Figure 2). Two of those (Clusters 4 & 6) were only constituted by HM isolates while in the five remaining ones, at least one isolate arose from the hospital environment. Interestingly, in clusters 2 (8 isolates) and 7 (11 isolates), isolates from environmental samples belonging to APHMB rooms were found to aggregate with HM ones. When a closer look was taken at the time sequence in which clusters 2 & 7 isolates were recovered, we found in cluster 7 that the only B. cereus strain isolated in raw HM was the first one to be recovered along with its post-pasteurization counterpart and in cluster 2, it was a pasteurized HM isolate. According to FTIR spectra analysis, similar isolates were thereafter harvested from all 3 APHBM rooms in cluster 7 and 2 out of the three APHBM rooms in cluster 2, pointing out that an environmental contamination by the HM donation of one mother could have spread to the environment and other HM donations. It is noteworthy that the first post-pasteurization isolate in cluster 7 was positive for ces but only one environmental isolate in the same cluster carried ces. Also of interest is the fact that this link between an environmental isolate and some HM ones found in cluster 7 was also highlighted in a previous analysis using rep-PCR [3]. However, this latter method is less suited to a routine determination of isolates' proximity as it is much more time-consuming and costly as well as less discriminating than FTIR spectroscopy. In our case, a closer monitoring of the environment and systematic real-time use of FTIR spectroscopy on B. cereus isolates could have helped in limiting the spread of this clone in APHBM as well as the one identified in cluster 2 for which a similar pattern. It might therefore be interesting to implement such a monitoring routinely. Comparing the results obtained through this technique with those of WGS would also help strengthening the daily use of FITR if a good correlation for clonality assessment is found.

    This study is one of the first papers reporting on toxin gene prevalences in HM B. cereus isolates and highlights that about one fourth of those are expressing cereulide toxin, which could be worrisome from a public health point of view and call for preventative measures. It is also one of the first reports on B. cereus clustering through FTIR Spectroscopy, which proved efficient, time and cost-effective. The use of this technique pointed out that some HM B. cereus isolates clustered with APHMB environmental isolates. This is an indication that mitigation measures such as a thorough cleaning procedure following several occurrences of B. cereus isolation in a short time span and/or B. cereus detection in routine environmental samples could be implemented to reduce the isolation of B. cereus in HM donations and the rejection of thusly contaminated donations.



    [1] M. M. Hoeper, M. Humbert, R. Souza, M. Idrees, S. M. Kawut, K. Sliwa-Hahnle, et al., A global view of pulmonary hypertension, Lancet Respir. Med., 4 (2016), 306–322. https://doi.org/10.1016/s2213-2600(15)00543-3 doi: 10.1016/s2213-2600(15)00543-3
    [2] H. Zeng, X. Liu, Y. Zhang, Identification of potential biomarkers and immune infiltration characteristics in idiopathic pulmonary arterial hypertension using bioinformatics analysis, Front. Cardiovasc. Med., 8 (2021). https://doi.org/10.3389/fcvm.2021.624714 doi: 10.3389/fcvm.2021.624714
    [3] N. Galiè, M. Humbert, J. Vachiery, S. Gibbs, I. Lang, A. Torbicki, et al., 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension, Rev. Esp. Cardiol. (Engl. Ed.), 69 (2016), 177. https://doi.org/10.1016/j.rec.2016.01.002 doi: 10.1016/j.rec.2016.01.002
    [4] V. V. McLaughlin, M. D. McGoon, Pulmonary Arterial Hypertension, Circulation, 114 (2006), 1417–1431. https://doi.org/10.1161/CIRCULATIONAHA.104.503540 doi: 10.1161/CIRCULATIONAHA.104.503540
    [5] P. Pahal, S. Sharma, Idiopathic Pulmonary Artery Hypertension, StatPearls Publishing, Florida, 2022.
    [6] E. Spiekerkoetter, S. M. Kawut, V. A. de Jesus Perez, New and emerging therapies for pulmonary arterial hypertension, Annu. Rev. Med., 70 (2019), 45–59. https://doi.org/10.1146/annurev-med-041717-085955 doi: 10.1146/annurev-med-041717-085955
    [7] J. Y. Cao, K. M. Wales, R. Cordina, E. M. T. Lau, D. S. Celermajer, Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis, Int. J. Cardiol., 273 (2018), 213–220. https://doi.org/10.1016/j.ijcard.2018.09.043 doi: 10.1016/j.ijcard.2018.09.043
    [8] L. Yan, Q. Luo, Z. Zhao, Q. Zhao, Q. Jin, Y. Zhang, et al., Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension, Pulm. Circ., 10 (2020), 1–7. https://doi.org/10.1177/2045894019885364 doi: 10.1177/2045894019885364
    [9] N. W. Morrell, M. A. Aldred, W. K. Chung, C. G. Elliott, W. C. Nichols, F. Soubrier, et al., Genetics and genomics of pulmonary arterial hypertension, Eur. Respir. J., 53 (2019), 1801899. https://doi.org/10.1183/13993003.01899-2018 doi: 10.1183/13993003.01899-2018
    [10] M. A. Aldred, J. Vijayakrishnan, V. James, F. Soubrier, M. A. Gomez-Sanchez, G. Martensson, et al., BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension, Hum. Mutat., 27 (2006), 212–213. https://doi.org/10.1002/humu.9398 doi: 10.1002/humu.9398
    [11] S. H. Choi, Y. Jung, J. Jang, S. Han, Idiopathic pulmonary arterial hypertension associated with a novel frameshift mutation in the bone morphogenetic protein receptor Ⅱ gene and enhanced bone morphogenetic protein signaling, Medicine, 98 (2019), e17594. https://doi.org/10.1097/MD.0000000000017594 doi: 10.1097/MD.0000000000017594
    [12] A. Chida, M. Shintani, T. Nakayama, Y. Furutani, E. Hayama, K. Inai, et al., Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension, Circ. J., 76 (2012), 1501–1508. https://doi.org/10.1253/circj.cj-11-1281 doi: 10.1253/circj.cj-11-1281
    [13] D. Saygin, T. Tabib, H. E. T. Bittar, E. Valenzi, J. Sembrat, S. Y. Chan, et al., Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension, Pulm. Circ., 10 (2020), 1–15. https://doi.org/10.1177/2045894020908782 doi: 10.1177/2045894020908782
    [14] Y. Wu, J. Wharton, R. Walters, E. Vasilaki, J. Aman, L. Zhao, et al., The pathophysiological role of novel pulmonary arterial hypertension gene SOX17, Eur. Respir. J., (2021). https://doi.org/10.1183/13993003.04172-2020 doi: 10.1183/13993003.04172-2020
    [15] C. S. Park, S. H. Kim, H. Y. Yang, J. Kim, R. T. Schermuly, Y. S. Cho, et al., Sox17 deficiency promotes pulmonary arterial hypertension via HGF/c-Met signaling, Circ. Res., 131 (2022), 792–806. https://doi.org/10.1161/CIRCRESAHA.122.320845 doi: 10.1161/CIRCRESAHA.122.320845
    [16] T. Wang, S. Wang, Y. Xu, C. Zhao, X. Qiao, C. Yang, et al., SOX17 loss-of-function mutation underlying familial pulmonary arterial hypertension, Int. Heart. J., 62 (2021), 566–574. https://doi.org/10.1536/ihj.20-711 doi: 10.1536/ihj.20-711
    [17] N. Zhu, C. L. Welch, J. Wang, P. M. Allen, C. Gonzaga-Jauregui, L. Ma, et al., Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease, Genome Med., 56 (2018). https://doi.org/10.1186/s13073-018-0566-x doi: 10.1186/s13073-018-0566-x
    [18] X. Yuan, Z. Wang, L. Wang, Q. Zhao, S. Gong, Y. Sun, et al., Increased levels of runt-related transcription factor 2 are associated with poor survival of patients with idiopathic pulmonary arterial hypertension, Am. J. Men's Health., 14 (2020). https://doi.org/10.1177/1557988320945458 doi: 10.1177/1557988320945458
    [19] L. C. Price, S. J. Wort, F. Perros, P. Dorfmüller, A. Huertas, D. Montani, et al., Inflammation in pulmonary arterial hypertension, Chest, 141 (2012), 210–221. https://doi.org/10.1378/chest.11-0793 doi: 10.1378/chest.11-0793
    [20] H. Zeng, X. Liu, Y. Zhang, Identification of potential biomarkers and immune infiltration characteristics in idiopathic pulmonary arterial hypertension using bioinformatics analysis, Front. Cardiovasc. Med., 8 (2021). https://doi.org/10.3389/fcvm.2021.624714 doi: 10.3389/fcvm.2021.624714
    [21] I. Sarrion, L. Milian, G. Juan, M. Ramon, I. Furest, C. Carda, et al., Role of circulating miRNAs as biomarkers in idiopathic pulmonary arterial hypertension: Possible relevance of miR-23a, Oxid. Med. Cell. Longevity, 2015 (2015), 792846. https://doi.org/10.1155/2015/792846 doi: 10.1155/2015/792846
    [22] W. He, X. Su, L. Chen, C. Liu, W. Lu, T. Wang, et al., Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension, Physiol. Rep., 10 (2022), e15101. https://doi.org/10.14814/phy2.15101 doi: 10.14814/phy2.15101
    [23] C. Li, Z. Zhang, Q. Xu, R. Shi, Comprehensive analyses of miRNA-mRNA network and potential drugs in idiopathic pulmonary arterial hypertension, BioMed Res. Int., 2020 (2020), 5156304. https://doi.org/10.1155/2020/5156304 doi: 10.1155/2020/5156304
    [24] S. Hao, P. Jiang, L. Xie, G. Xiang, Z. Liu, W. Hu, et al., Essential genes and MiRNA-mRNA network contributing to the pathogenesis of idiopathic pulmonary arterial hypertension, Front. Cardiovasc. Med., 8 (2021), 627873. https://doi.org/10.3389/fcvm.2021.627873 doi: 10.3389/fcvm.2021.627873
    [25] D. Li, A. Tulahong, M. N. Uddin, H. Zhao, H. Zhang, Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer, Math. Biosci. Eng., 18 (2021), 6527–6551. https://doi.org/10.3934/mbe.2021324 doi: 10.3934/mbe.2021324
    [26] E. Hsu, H. Shi, R. M. Jordan, J. Lyons-Weiler, J. M. Pilewski, C. A. Feghali-Bostwick, Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension, Arthritis Rheum., 63 (2011), 783–794. https://doi.org/10.1002/art.30159 doi: 10.1002/art.30159
    [27] L. Renaud, W. A. da Silveira, N. Takamura, G. Hardiman, C. Feghali-Bostwick, Prominence of IL6, IGF, TLR, and bioenergetics pathway perturbation in lung tissues of scleroderma patients with pulmonary fibrosis, front. immunol., 11 (2020), 383. https://doi.org/10.3389/fimmu.2020.00383 doi: 10.3389/fimmu.2020.00383
    [28] M. Mura, M. J. Cecchini, M. Joseph, J. T. Granton, Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension, Respirology, 24 (2019), 1104–1110. https://doi.org/10.1111/resp.13557 doi: 10.1111/resp.13557
    [29] R. S. Stearman, Q. M. Bui, G. Speyer, A. Handen, A. R. Cornelius, B. B. Graham, et al., Systems analysis of the human pulmonary arterial hypertension lung transcriptome, Am. J. Respir. Cell Mol. Biol., 60 (2019), 637–649. https://doi.org/10.1165/rcmb.2018-0368OC doi: 10.1165/rcmb.2018-0368OC
    [30] C. E. Romanoski, X. Qi, S. Sangam, R. R. Vanderpool, R.S. Stearman, A. Conklin, et al., Transcriptomic profiles in pulmonary arterial hypertension associate with disease severity and identify novel candidate genes, Pulm. Circ., 10 (2020). https://doi.org/10.1177/2045894020968531 doi: 10.1177/2045894020968531
    [31] C. Cheadle, A. E. Berger, S. C. Mathai, D. N. Grigoryev, T. N. Watkins, Y. Sugawara, et al., Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patients, PloS One., 7 (2012), e34951. https://doi.org/10.1371/journal.pone.0034951 doi: 10.1371/journal.pone.0034951
    [32] D. Wu, C. C. Talbot, Q. Liu, Z. Jing, R. L. Damico, R. Tuder et al., Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension, J. Mol. Med., 94 (2016), 875–885. https://doi.org/10.1007/s00109-016-1426-z doi: 10.1007/s00109-016-1426-z
    [33] J. Xia, E. E. Gill, R. E. W. Hancock, NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data, Nat. Protoc., 10 (2015), 823–844. https://doi.org/10.1038/nprot.2015.052 doi: 10.1038/nprot.2015.052
    [34] W. E. Johnson, C. Li, A. Rabinovic, Adjusting batch effects in microarray expression data using empirical bayes methods, Biostatistics, 8 (2007), 118–127. https://doi.org/10.1093/biostatistics/kxj037 doi: 10.1093/biostatistics/kxj037
    [35] M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law, W. Shi, et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res., 43 (2015), e47. https://doi.org/10.1093/nar/gkv007 doi: 10.1093/nar/gkv007
    [36] A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, PNAS, 102 (2005), 15545–15550. https://doi.org/10.1073/pnas.0506580102 doi: 10.1073/pnas.0506580102
    [37] D. Szklarczyk, A. L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, et al., STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic Acids Res., 47 (2019), 607–613. https://doi.org/10.1093/nar/gky1131 doi: 10.1093/nar/gky1131
    [38] C. Chin, S. Chen, H. Wu, C. Ho, M. Ko, C. Lin, CytoHubba: identifying hub objects and sub-networks from complex interactome, BMC Syst. Biol., 8 (2014), S11. https://doi.org/10.1186/1752-0509-8-S4-S11 doi: 10.1186/1752-0509-8-S4-S11
    [39] J. Wang, R. Akter, M. F. Shahriar, M. N. Uddin, Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer, Pathol. Oncol. Res., (2022). https://doi.org/10.3389/pore.2022.1610350 doi: 10.3389/pore.2022.1610350
    [40] P. Shannon, A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks, Genome Res., 13 (2003), 2498–2504. https://doi.org/10.1101/gr.1239303 doi: 10.1101/gr.1239303
    [41] Y. Fan, K. Siklenka, S. K. Arora, P. Ribeiro, S. Kimmins, J. Xia, MiRNet-dissecting miRNA-target interactions and functional associations through network-based visual analysis, Nucleic Acids Res., 44 (2016), 135–141. https://doi.org/10.1093/nar/gkw288 doi: 10.1093/nar/gkw288
    [42] X. Robin, N. Turck, A. Hainard, N. Tiberti, F. Lisacek, J. Sanchez, M. Müller, PROC: an open-source package for R and S+ to analyze and compare ROC curves, BMC Bioinformatics., 77 (2011). https://doi.org/10.1186/1471-2105-12-77 doi: 10.1186/1471-2105-12-77
    [43] J. Wang, M. N. Uddin, J. Hao, R. Chen, Y. Xiang, D. Xiong, et al., Identification of potential novel prognosis-related genes through transcriptome sequencing, bioinformatics analysis, and clinical validation in acute myeloid leukemia, Front. Genet., 12 (2021). https://doi.org/10.3389/fgene.2021.723001 doi: 10.3389/fgene.2021.723001
    [44] M. N. Uddin, R. Akter, M. Li, Z. Abdelrahman, Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles, Chem. Biol. Interact., 335 (2021), 109370. https://doi.org/10.1016/j.cbi.2021.109370 doi: 10.1016/j.cbi.2021.109370
    [45] K. C. Cotto, A. H. Wagner, Y. Feng, S. Kiwala, A. C. Coffman, G. Spies, et al., DGIdb 3.0: A redesign and expansion of the drug-gene interaction database, Nucleic Acids Res., 46 (2018), 1068–1073. https://doi.org/10.1093/nar/gkx1143 doi: 10.1093/nar/gkx1143
    [46] X. Mao, Z. Ren, G. N. Parker, H. Sondermann, M. A. Pastorello, W. Wang, et al., Structural bases of unphosphorylated STAT1 association and receptor binding, Mol. Cell, 17 (2005), 761–771. https://doi.org/10.1016/j.molcel.2005.02.021 doi: 10.1016/j.molcel.2005.02.021
    [47] A. Yamamura, M. J. Nayeem, A. A. Mamun, R. Takahashi, H. Hayashi, M. Sato, Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension, FASEB J., 33 (2019), 7363–7374. https://doi.org/10.1096/fj.201802620R doi: 10.1096/fj.201802620R
    [48] S. Gairhe, K. S. Awad, E. J. Dougherty, G. A. Ferreyra, S. Wang, Z. Yu, et al., Type Ⅰ interferon activation and endothelial dysfunction in caveolin-1 insufficiency-associated pulmonary arterial hypertension, PNAS, 118 (2021). https://doi.org/10.1073/pnas.2010206118 doi: 10.1073/pnas.2010206118
    [49] A. D. Stefano, G. Caramori, A. Capelli, I. Gnemmi, F. L. Ricciardolo, T. Oates, et al., STAT4 activation in smokers and patients with chronic obstructive pulmonary disease, Eur. Respir. J., 24 (2004), 78–85. https://doi.org/10.1183/09031936.04.00080303 doi: 10.1183/09031936.04.00080303
    [50] H. Alam, N. Li, S. S. Dhar, S. J. Wu, J. Lv, K. Chen, et al., HP1γ promotes lung adenocarcinoma by downregulating the transcription-repressive regulators NCOR2 and ZBTB7A, Cancer Res., 78 (2018), 3834–3848. https://doi.org/10.1158/0008-5472.CAN-17-3571 doi: 10.1158/0008-5472.CAN-17-3571
    [51] Y. Yang, H. Yuan, J. G. Edwards, Y. Skayian, K. Ochani, E. J. Miller, et al., Deletion of STAT5a/b in vascular smooth muscle abrogates the male bias in hypoxic pulmonary hypertension in mice: Implications in the human disease, Mol. Med., 20 (2014), 625–638. https://doi.org/10.2119/molmed.2014.00180 doi: 10.2119/molmed.2014.00180
    [52] T. Hashimoto-Kataoka, N. Hosen, T. Sonobe, Y. Arita, T. Yasui, T. Masaki, et al., Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension, PNAS, 112 (2015), 2677–2686. https://doi.org/10.1073/pnas.1424774112 doi: 10.1073/pnas.1424774112
    [53] E. Zhao, H. Xie, Y. Zhang, Identification of differentially expressed genes associated with idiopathic pulmonary arterial hypertension by integrated bioinformatics approaches, J. Comput. Biol., 28 (2021), 79–88. https://doi.org/10.1089/cmb.2019.0433 doi: 10.1089/cmb.2019.0433
    [54] W. Wang, Z. Jiang, D. Zhang, L. Fu, R. Wan, K. Hong, Comparative transcriptional analysis of pulmonary arterial hypertension associated with three different diseases, Front. Cell Dev. Biol., 9 (2021). https://doi.org/10.3389/fcell.2021.672159 doi: 10.3389/fcell.2021.672159
    [55] H. Göös, M. Kinnunen, K. Salokas, Z. Tan, X. Liu, L. Yadav, et al., Human transcription factor protein interaction networks, Nat. Commun., 13 (2022), 766. https://doi.org/10.1038/s41467-022-28341-5 doi: 10.1038/s41467-022-28341-5
    [56] Q. Yang, C. Jia, P. Wang, M. Xiong, J. Cui, L. Li, et al., MicroRNA-505 identified from patients with essential hypertension impairs endothelial cell migration and tube formation, Int. J. Cardiol., 177 (2014), 925–934. https://doi.org/10.1016/j.ijcard.2014.09.204 doi: 10.1016/j.ijcard.2014.09.204
    [57] H. Wang, Z. Ma, X. Liu, C. Zhang, Y. Hu, L. Ding, et al., MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN, Biomed. Pharmacother., 111 (2019), 1103–1111. https://doi.org/10.1016/j.biopha.2018.12.115 doi: 10.1016/j.biopha.2018.12.115
    [58] J. Li, S. Sun, N. Li, P. Lv, S. Xie, P. Wang, MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer, Oncotarget, 8 (2017), 91938–91949. https://doi.org/10.18632/oncotarget.20262 doi: 10.18632/oncotarget.20262
    [59] Y. Zhao, J. Zhang, J. Yang, Y. Wei, J. Peng, C. Fu, et al., MiR-205-5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer, Thorac Cancer, 13 (2022), 832–843. https://doi.org/10.1111/1759-7714.14331 doi: 10.1111/1759-7714.14331
    [60] W. Liu, X. Wan, Z. Mu, F. Li, L. Wang, J. Zhao, et al., MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1, Oncol. Lett., 16 (2018), 1708–1714. https://doi.org/10.3892/ol.2018.8794 doi: 10.3892/ol.2018.8794
    [61] H. El Chami, P. M. Hassoun, Immune and inflammatory mechanisms in pulmonary arterial hypertension, Prog. Cardiovasc. Dis., 55 (2012), 218–228. https://doi.org/10.1016/j.pcad.2012.07.006 doi: 10.1016/j.pcad.2012.07.006
    [62] N. M. Patel, S. M. Kawut, S. Jelic, S. M. Arcasoy, D. J. Lederer, A. C. Borczuk, Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis, Eur. Respir. J., 41 (2013), 1324–1330. https://doi.org/10.1183/09031936.00084112 doi: 10.1183/09031936.00084112
    [63] H. Yang, Y. Lu, H. Yang, Y. Zhu, Y. Tang, L. Li, et al., Integrated weighted gene co-expression network analysis uncovers STAT1(signal transducer and activator of transcription 1) and IFI44L (interferon-induced protein 44-like) as key genes in pulmonary arterial hypertension, Bioengineered, 12 (2021), 6021–6034. https://doi.org/10.1080/21655979.2021.1972200 doi: 10.1080/21655979.2021.1972200
    [64] L. Gabryšová, M. Alvarez-Martinez, R. Luisier, L. S. Cox, J. Sodenkamp, C. Hosking, et al., C-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells, Nat. Immunol., 19 (2018), 497–507. https://doi.org/10.1038/s41590-018-0083-5 doi: 10.1038/s41590-018-0083-5
    [65] X. Yang, C. Wang, Y. Lin, P. Zhang, Identification of crucial hub genes and differential T cell infiltration in idiopathic pulmonary arterial hypertension using bioinformatics strategies, Front. Mol. Biosci., 9 (2022). https://doi.org/10.3389/fmolb.2022.800888 doi: 10.3389/fmolb.2022.800888
    [66] S. Ni, T. Ji, J. Dong, F. Chen, H. Feng, H. Zhao, et al., Immune cells in pulmonary arterial hypertension, Heart Lung Circ., 31 (2022), 934–943. https://doi.org/10.1016/j.hlc.2022.02.007 doi: 10.1016/j.hlc.2022.02.007
    [67] M. Rabinovitch, C. Guignabert, M. Humbert, M. R. Nicolls, Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circ. Res., 115 (2014), 165–175. https://doi.org/10.1161/CIRCRESAHA.113.301141 doi: 10.1161/CIRCRESAHA.113.301141
    [68] M. Masullo, M. Menegazzi, S. Di Micco, P. Beffy, G. Bifulco, M. Dal Bosco, et al., Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT-1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways, J. Nat. Prod., 77 (2014), 543–549. https://doi.org/10.1021/np400804y doi: 10.1021/np400804y
    [69] M. Toshner, E. Spiekerkoetter, H. Bogaard, G. Hansmann, S. Nikkho, K. W. Prins, Repurposing of medications for pulmonary arterial hypertension, Pulm. Circ., 10 (2020). https://doi.org/10.1177/2045894020941494 doi: 10.1177/2045894020941494
    [70] R. Papp, C. Nagaraj, D. Zabini, B. M. Nagy, M. Lengyel, D. S. Maurer, et al., Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension, Eur. Respir. J., 53 (2019). https://doi.org/10.1183/13993003.00965-2018 doi: 10.1183/13993003.00965-2018
  • mbe-20-02-194 supplementary.xlsx
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2890) PDF downloads(141) Cited by(4)

Figures and Tables

Figures(9)  /  Tables(3)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog